Resveratrol has been shown to modify the AMPK/SIRT1 signaling pathway, crucial for regulating autophagy, cell death, and lipid metabolism as NAFLD worsens (89). This evidence concerns the gene PRKAA1 and metabolic dysfunction-associated steatotic liver disease.